The engagement establishes a multi-phase framework to support AI enabled capital efficient development of Teverelix, a next generation GnRH antagonist, as a first in class market product for acute ...
VANCOUVER, BC / ACCESS Newswire / January 5, 2026 / Prince Silver Corp. (CSE:PRNC)(OTCQB:PRNCF)(Frankfurt:T130) (“Prince Silver”) or, the “Company, is pleased to provide a corporate update and outline ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback